A Comprehensive Investigation of Genomic Variants in Prostate Cancer Reveals 30 Putative Regulatory Variants
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032472 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mahdieh Labani und 3 weiteren Autor:innen. Beteiligte Einrichtung: BioMedical Machine Learning Lab (BML), The Graduate School of Biomedical Engineering, UNSW Sydney, Sydney, NSW 2052, Australia. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Prostatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UNSW Sydney, UNSW Scientia Program Fellowship, Macquarie PhD Scholarship.
Abstract (Originalsprache)
Prostate cancer (PC) is the most frequently diagnosed non-skin cancer in the world. Previous studies have shown that genomic alterations represent the most common mechanism for molecular alterations responsible for the development and progression of PC. This highlights the importance of identifying functional genomic variants for early detection in high-risk PC individuals. Great efforts have been made to identify common protein-coding genetic variations; however, the impact of non-coding variations, including regulatory genetic variants, is not well understood. Identification of these variants and the underlying target genes will be a key step in improving the detection and treatment of PC. To gain an understanding of the functional impact of genetic variants, and in particular, regulatory variants in PC, we developed an integrative pipeline (AGV) that uses whole genome/exome sequences, GWAS SNPs, chromosome conformation capture data, and ChIP-Seq signals to investigate the potential impact of genomic variants on the underlying target genes in PC. We identified 646 putative regulatory variants, of which 30 significantly altered the expression of at least one protein-coding gene. Our analysis of chromatin interactions data (Hi-C) revealed that the 30 putative regulatory variants could affect 131 coding and non-coding genes. Interestingly, our study identified the 131 protein-coding genes that are involved in disease-related pathways, including Reactome and MSigDB, for most of which targeted treatment options are currently available. Notably, our analysis revealed several non-coding RNAs, including RP11-136K7.2 and RAMP2-AS1, as potential enhancer elements of the protein-coding genes CDH12 and EZH1, respectively. Our results provide a comprehensive map of genomic variants in PC and reveal their potential contribution to prostate cancer progression and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BioMedical Machine Learning Lab (BML), The Graduate School of Biomedical Engineering, UNSW Sydney, Sydney, NSW 2052, Australia.
- Data Analytic Lab, Department of Computing, Macquarie University, Sydney, NSW 2109, Australia.
- The Graduate School of Biomedical Engineering, UNSW Sydney, Sydney, NSW 2052, Australia.
- UNSW Data Science Hub, The University of New South Wales, Sydney, NSW 2052, Australia.
- Health Data Analytics Program, Centre for Applied AI, Macquarie University, Sydney, NSW 2109, Australia.
ORCID-Profile: Amin Beheshti
Förderung
- UNSW Sydney
- UNSW Scientia Program Fellowship
- Macquarie PhD Scholarship
Zitieren
APA
Labani, M., Beheshti, A., Argha, A., & Alinejad-Rokny, H. (2023). A Comprehensive Investigation of Genomic Variants in Prostate Cancer Reveals 30 Putative Regulatory Variants. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032472
Vancouver
Labani M, Beheshti A, Argha A, Alinejad-Rokny H. A Comprehensive Investigation of Genomic Variants in Prostate Cancer Reveals 30 Putative Regulatory Variants. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032472
BibTeX
@article{Labani2023,
author = {Labani, Mahdieh and Beheshti, Amin and Argha, Ahmadreza and Alinejad-Rokny, Hamid},
title = {A Comprehensive Investigation of Genomic Variants in Prostate Cancer Reveals 30 Putative Regulatory Variants},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032472}
}
EUVIMED